Filing Details
- Accession Number:
- 0001209191-15-084522
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-10 17:42:11
- Reporting Period:
- 2015-12-08
- Filing Date:
- 2015-12-10
- Accepted Time:
- 2015-12-10 17:42:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1277256 | Miguel Madero | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-12-08 | 6,000 | $5.95 | 18,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-08 | 12,000 | $2.35 | 30,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-08 | 12,000 | $3.60 | 42,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-08 | 12,000 | $18.00 | 54,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-08 | 12,000 | $3.50 | 66,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-08 | 12,000 | $9.78 | 78,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-08 | 6,000 | $18.34 | 84,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-12-08 | 12,000 | $2.90 | 96,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-12-08 | 40,386 | $30.49 | 55,614 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-12-08 | 6,000 | $0.00 | 6,000 | $5.95 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-12-08 | 12,000 | $0.00 | 12,000 | $2.35 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-12-08 | 12,000 | $0.00 | 12,000 | $3.60 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-12-08 | 12,000 | $0.00 | 12,000 | $18.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-12-08 | 12,000 | $0.00 | 12,000 | $3.50 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-12-08 | 12,000 | $0.00 | 12,000 | $9.78 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-12-08 | 6,000 | $0.00 | 6,000 | $18.34 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2015-12-08 | 12,000 | $0.00 | 12,000 | $2.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-06-27 | No | 4 | M | Direct | |
| 0 | 2018-03-12 | No | 4 | M | Direct | |
| 0 | 2019-03-11 | No | 4 | M | Direct | |
| 0 | 2014-11-13 | No | 4 | M | Direct | |
| 0 | 2021-03-15 | No | 4 | M | Direct | |
| 0 | 2023-04-17 | No | 4 | M | Direct | |
| 6,000 | 2025-06-03 | No | 4 | M | Direct | |
| 0 | 2020-06-09 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 369,632 | Indirect | See footnote |
Footnotes
- The shares were sold by the reporting person to cover the exercise price and the taxes realized upon the exercise of such options.
- The shares were sold at prices ranging from $30.35 to $30.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares are held in accounts for the benefit of family members of the reporting person. The reporting person maintains voting and dispositive power over the shares held in such accounts.
- Fully vested.
- The shares subject to the option vest and become exercisable quarterly over one year measured from June 3, 2015.
Billionaire Hedge Funds
